Skip to main content
. Author manuscript; available in PMC: 2012 Aug 19.
Published in final edited form as: Health Aff (Millwood). 2010 Oct 28;29(12):2335–2343. doi: 10.1377/hlthaff.2009.0323
Risk Adjuster Non-LIS
Subjects
LIS Subjects

MAPE Adj
R^2
MAPE Adj
R^2
Demographics Age+gender 620 0.0108 737 0.0084

RxHCC RxHCC (score) 520 0.2056 612 0.2438

Prior Drug RxClass (48 indicators) 406 0.4105 526 0.3833
Information Cost (annualized) 420 0.4776 478 0.5687

RxHCC+
Prior Drug
RxHCC+RxClass
(48 indicators)
403 0.4173 516 0.4118
Use Info RxHCC+Prior Cost
(annualized)
392 0.5225 451 0.6034

Source: Authors’ analysis

Notes: Includes all subjects with at least one month of enrollment in 2006. Cost (annualized) = 12*actual drug expenditure in 2006/months of enrollment in 2006. The MAPE (Mean Absolute Prediction Error) is the average of the absolute difference between the predicted and actual plan liability for each subject.